Richard C. Young & Co’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.36M Sell
15,968
-351
-2% -$31.3K 0.11% 67
2025
Q4
$1.29M Sell
16,319
-1,232
-7% -$96.6K 0.12% 69
2025
Q3
$1.4M Sell
17,551
-80,092
-82% -$6.83M 0.13% 68
2025
Q2
$8.88M Buy
97,643
+181
+0.2% +$16.5K 0.88% 48
2025
Q1
$9.13M Buy
97,462
+7,554
+8% +$676K 0.98% 47
2024
Q4
$8.17M Buy
89,908
+959
+1% +$91.5K 0.89% 49
2024
Q3
$9.23M Buy
88,949
+5,020
+6% +$512K 1.01% 50
2024
Q2
$8.14M Buy
83,929
+4,421
+6% +$408K 0.99% 50
2024
Q1
$7.16M Sell
79,508
-1,798
-2% -$152K 0.9% 51
2023
Q4
$6.48M Sell
81,306
-1,871
-2% -$141K 0.87% 50
2023
Q3
$5.91M Sell
83,177
-1,951
-2% -$146K 0.84% 51
2023
Q2
$6.56M Sell
85,128
-2,377
-3% -$184K 0.9% 51
2023
Q1
$6.58M Sell
87,505
-4,247
-5% -$316K 0.91% 50
2022
Q4
$7.23M Sell
91,752
-4,667
-5% -$350K 0.96% 46
2022
Q3
$6.77M Sell
96,419
-2,698
-3% -$212K 1.04% 44
2022
Q2
$7.94M Sell
99,117
-1,865
-2% -$146K 1.03% 46
2022
Q1
$7.66M Sell
100,982
-3,298
-3% -$261K 0.98% 49
2021
Q4
$8.9M Buy
104,280
+7,820
+8% +$611K 1.12% 41
2021
Q3
$7.29M Buy
96,460
+8,456
+10% +$671K 1% 43
2021
Q2
$7.16M Buy
88,004
+4,250
+5% +$348K 0.91% 51
2021
Q1
$6.6M Buy
83,754
+8,405
+11% +$659K 0.88% 51
2020
Q4
$6.44M Buy
75,349
+3,034
+4% +$251K 0.98% 43
2020
Q3
$5.58M Buy
72,315
+2,241
+3% +$171K 0.9% 44
2020
Q2
$5.13M Buy
70,074
+1,544
+2% +$110K 0.86% 45
2020
Q1
$4.55M Buy
68,530
+2,590
+4% +$183K 0.88% 45
2019
Q4
$4.54M Buy
65,940
+3,444
+6% +$235K 0.76% 51
2019
Q3
$4.59M Buy
62,496
+1,339
+2% +$97.1K 0.83% 49
2019
Q2
$4.38M Buy
61,157
+6,770
+12% +$481K 0.83% 48
2019
Q1
$3.73M Buy
54,387
+4,693
+9% +$303K 0.71% 53
2018
Q4
$2.96M Buy
+49,694
New +$3.11M 0.63% 48

Other funds holding CL

Richard C. Young & Co's CL Position: Q1 2026 in Review

Richard C. Young & Co reduced its Colgate-Palmolive (CL) stake by 2.2% in Q1 2026, selling an estimated $31.3K and leaving 15,968 shares worth $1.36M. The position accounts for 0.11% of the portfolio, ranked #67.

Richard C. Young & Co first reported a position in CL in Q4 2018 and has held it in 30 quarters since. The position peaked at $9.23M in Q3 2024. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Richard C. Young & Co held 15,968 shares of Colgate-Palmolive worth $1.36M as of Q1 2026.
  • Richard C. Young & Co sold 351 Colgate-Palmolive shares in Q1 2026, an estimated $31.3K.
  • Colgate-Palmolive made up 0.11% of Richard C. Young & Co's portfolio in Q1 2026, its #67 holding.
  • Richard C. Young & Co first reported a position in Colgate-Palmolive in Q4 2018 and has held it in 30 quarters since.
  • Richard C. Young & Co's Colgate-Palmolive position peaked at $9.23M in Q3 2024.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Richard C. Young & Co's 13F filing for Q1 2026, filed 7 May 2026.